• Protean BioDiagnostics Lung HDPCR™ for Non-Small Cell Lung Cancer (NSCLC)
  • Factor V (Leiden) Mutation
  • Striated Muscle Antibodies, IgG
  • 6-Monoacetylmorphine (6-MAM) Confirmation, Urine
  • Enterovirus, Real-time PCR, CSF
  • Uveal melanoma gene expression profiling by real-time RT-PCR
  • Rubella Virus RNA, Real-Time PCR
  • TGFBI Gene Mutation Analysis
  • Calcium, Random, Urine
  • DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Specimen Collection
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...